Patterson (Patterson) Cash And Cash Equivalents : $124 Mil (As of Jan. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Patterson Cash And Cash Equivalents?

Patterson's quarterly cash and cash equivalents increased from Jul. 2023 ($108.57 Mil) to Oct. 2023 ($113.89 Mil) and increased from Oct. 2023 ($113.89 Mil) to Jan. 2024 ($124.00 Mil).

Patterson's annual cash and cash equivalents declined from Apr. 2021 ($143.24 Mil) to Apr. 2022 ($142.01 Mil) but then increased from Apr. 2022 ($142.01 Mil) to Apr. 2023 ($159.67 Mil).

Patterson Cash And Cash Equivalents Historical Data

The historical data trend for Patterson's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Patterson Cash And Cash Equivalents Chart

Patterson Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Cash And Cash Equivalents

Get a 7-Day Free Trial

95.65

77.94

143.24

142.01

159.67

Patterson Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Cash And Cash Equivalents	Get a 7-Day Free Trial															147.29	159.67	108.57	113.89	124.00

Patterson Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Patterson (NAS:PDCO) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Patterson Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Patterson's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Patterson (Patterson) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Patterson Companies Inc (NAS:PDCO) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

PD2:Germany PD2:Germany

Address

1031 Mendota Heights Road, Saint Paul, MN, USA, 55120

Website

https://www.pattersoncompanies.com

Patterson Companies Inc is a leading dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives a majority of its revenue from the United States.

Executives

Kevin Michael Barry	officer: Chief Financial Officer	1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Donald Zurbay	officer: Chief Financial Officer	C/O ST. JUDE MEDICAL, INC., ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117
Timothy E Rogan	officer: President - Dental	1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Les B Korsh	officer: VP, General Counsel	1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55110
Meenu Agarwal	director	7246 E MERCER WAY, MERCER ISLAND WA 98040
Samantha L Bergeson	officer: CHRO	1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Andrea L. Frohning	officer: Chief Human Resources Officer	C/O DENTSLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Philip Mckoy	director	120 BROADWAY, SUITE 200, SANTA MONICA CA 90401
Jody H Feragen	director	1 HORMEL PLACE, AUSTIN TX 55912
Eric R Shirley	officer: President-Patterson Dental	1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Francis Joseph Malecha	director	9900 WEST 109TH STREET, SUITE 100, OVERLAND PARK KS 66210
Robert Frenzel	director	414 NICOLLET MALL, MINNEAPOLIS MN 55401
Dennis W Goedken	officer: Interim CFO	1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Ann B Gugino	officer: Vice President	1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
John D Buck	director	4201 GULF SHORE BLVD NORTH, APT 1703N, NAPLES FL 34103